(Q43668186)

25 November 2017

Effects of forebrain microinjection of cholecystokinin on dopamine cell firing rate (English)

1 reference

25 November 2017

1 reference

Hamilton ME

1

1 reference

PubMed ID

11445235

25 November 2017

Weddige FK

series ordinal

2

1 reference

PubMed ID

11445235

25 November 2017

Freeman AS

series ordinal

3

1 reference

25 November 2017

1 July 2001

1 reference

25 November 2017

7

1 reference

inferred from page(s)

published in

Peptides

1 reference

25 November 2017

22

1 reference

25 November 2017

7

1 reference

25 November 2017

1063-1069

1 reference

Neuropeptide modulation of apomorphine-induced stereotyped behavior

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Amygdalonigral pathway: an anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Neurobiology of addiction. Toward the development of new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Cholecystokinergic innervation of nucleus accumbens subregions.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Substantia nigra and ventral tegmental area projections to cortex: Topography and collateralization

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Electrophysiological responses of neurons of the ventral tegmental area to electrical stimulation of amygdala and lateral septum

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Efferent connections and nigral afferents of the nucleus accumbens septi in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

A pharmacological analysis of the burst events induced in midbrain dopaminergic neurons by electrical stimulation of the prefrontal cortex in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

The actions of motilin, luteinizing hormone releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal peptide, and other peptides on rat cerebral cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Cholecystokinin and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Enkephalin-dopamine interactions in the central amygdalar nucleus during gastric stress ulcer formation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Effects of electrical stimulation of the central nucleus of the amygdala on the in vivo electrophysiological activity of rat nigral dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Diagonal ventral forebrain continuum has overlapping telencephalic inputs and brainstem outputs which may represent loci for limbic/autonomic integration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Synaptic regulation of mesocorticolimbic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900427-2

7 January 2021

10.1016/S0196-9781(01)00427-2

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

11445235